Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices

• 主要な著者: Bożena Szyguła-Jurkiewicz (著者), Wioletta Szczurek-Wasilewicz (著者), Mariusz Gąsior (著者), Izabela Copik (著者), Justyna Małyszek-Tumidajewicz (著者), Michał Skrzypek (著者), Ewa Romuk (著者), Michał Zembala (著者), Marian Zembala (著者), Piotr Przybyłowski (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2021-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Left ventricular assist device (LVAD) is well established as an alternative treatment for end-stage heart failure (HF) patients. The aim of the study was to determine the prognostic value of oxidative stress markers and the modified Model for End-Stage Liver Disease (modMELD) in patients receiving b...